Pharmafile Logo

Virtual Grant Writing & Review – Engaging Your Advisors Creatively

Boost your research initiatives! Discover how to creatively manage virtual grant writing & review programs with your KOLs, identifying key topics & streamlining proposal approvals. Foster impactful collaborations. Watch

Streamline your grant processes and foster impactful research. Explore how to leverage virtual solutions for grant writing, study proposal development, and comprehensive grant review programs with your Key Opinion Leaders (KOLs) and other advisors. Discover how to identify key research topics of mutual interest and efficiently collaborate on drafting proposals. You can easily conduct robust virtual programs for the review and approval of grants from independent researchers, ensuring thorough evaluation and seamless execution with engaging virtual solutions.

  1. Virtual Grant Writing or Grant Review Programs

    • Collaborate with KOLs to co-create study proposals and research grants.
    • Implement efficient virtual programs for reviewing and approving independent researcher grants.
    • Identify high-interest research topics among participants.
    • Determine advisors’ willingness to participate in grant drafting processes.

For more creative ways to engage your advisors, visit: https://www.impetusdigital.com/2019/11/15/top-10-creative-ways-to-engage-your-advisors/

Learn more about Impetus Digital’s solutions: www.impetusdigital.com

Schedule a consultation: https://meetwithimpetus.com/

Stay connected:

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Environmental impact of in-person vs. virtual meetings

Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events…

Leadership Lessons Learned from the Pandemic

Alok Kanti, President & CEO of Bayer Canada, discusses a variety of topics, including his experience with leading an entire organization through the COVID-19 pandemic and where he sees digital health…

Overcoming Behavioral Health Access Limitations Through Telemedicine

Phil Hirsh, PhD, Founder & Chief Executive at Synergia Integrated teleBehavioral Health; and Craig Wright, MD, Senior Physician Executive and Consultant, discuss a range of topics surrounding telemedicine and other digital health…

Commercial Execution Strategies During & After the Pandemic

Frank Armenante, Director of Commercial Execution at Novo Nordisk, discusses a range of topics, from the impact of COVID-19 on commercial operations and the digitization of Pharma to his leadership lessons…

Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal

Even after the pandemic is long behind us, virtual collaboration will become mainstay in Pharma.

Pharma, Technology, and Healthcare in the New Normal

Brian Canestraro, General Manager at Intercept Pharmaceuticals, discusses a range of hot topics, from Brian’s leadership lessons and tips to the impact of the COVID-19 pandemic on the way that Pharma…

Solving the Caregiver Crisis Through Technology

Curtis Khan, CEO and Founder of BookJane, discusses the ongoing caregiver crisis and how BookJane’s solutions and other digital technologies can help to close this gap. We also delve into how…

Therapeutic VR for Managing Pain & Improving Patient Outcomes

Ramsay Brown, CEO and Founder of Quol, delves into several different HealthTech topics, including the concept of VR therapeutics and the importance of incorporating behavioral science and neuroscience into VR solutions, as…

Visual Storytelling in HealthTech

Rodney Hu, founder of 209|Digital and a popular podcast host. We explore Rodney’s work within the HealthTech space and what he believes has to happen for the healthcare industry to more…

Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients

Sandra Graham-Mason, Director of Marketing at Regeneron Pharmaceuticals discusses a variety of topics, from the impact of COVID-19 on the way that Pharma teams interact with internal stakeholders and KOLs to…